Metsera

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$215M

Metsera is a clinical-stage biopharmaceutical company developing next-generation treatments for obesity and metabolic diseases using their innovative platforms and Nutrient-Stimulated Hormone analog peptides.